Caxton Corp Eiger Bio Pharmaceuticals, Inc. Transaction History

Caxton Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.12 - $8.19 $121,538 - $194,414	-23,738 Reduced 16.88%	116,884 $607,000
Q3 2021 Nov 15, 2021	BUY	$6.68 - $9.1 $13,333 - $18,163	1,996 Added 1.44%	140,622 $939,000
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.23 $348,326 - $411,131	44,543 Added 47.34%	138,626 $1.18 Million
Q1 2021 May 17, 2021	BUY	$8.44 - $12.66 $126,895 - $190,343	15,035 Added 19.02%	94,083 $833,000
Q4 2020 Feb 16, 2021	SELL	$7.98 - $12.29 $269,915 - $415,696	-33,824 Reduced 29.97%	79,048 $972,000
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $245,876 - $383,641	30,889 Added 37.68%	112,872 $919,000
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $1,976 - $4,893	366 Added 0.45%	81,983 $787,000
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $95,848 - $286,958	19,521 Added 31.44%	81,617 $555,000
Q4 2019 Feb 14, 2020	BUY	$9.77 - $15.66 $791 - $1,268	81 Added 0.13%	62,096 $925,000
Q3 2019 Nov 14, 2019	BUY	$9.59 - $12.0 $1,342 - $1,680	140 Added 0.23%	62,015 $636,000
Q2 2019 Aug 14, 2019	BUY	$9.54 - $14.96 $120,108 - $188,346	12,590 Added 25.55%	61,875 $656,000
Q1 2019 May 14, 2019	BUY	$10.31 - $14.38 $57,488 - $80,182	5,576 Added 12.76%	49,285 $689,000
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $157,195 - $225,866	18,215 Added 71.45%	43,709 $444,000
Q3 2018 Nov 14, 2018	BUY	$9.6 - $12.9 $244,742 - $328,872	25,494 New	25,494 $306,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

Stay updated on Caxton Corp with notifications on news.